If you ask the commissioner of the US Food and Drug Administration about the greatest hurdles to treating disease in the US, he doesn’t point to any of the scientific problems his agency is working on ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...

• Some successful regulatory science education and training programs offer a menu of educational opportunities that build core competencies while allowing participants to focus on aspects of ...

TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant to Odylia Therapeutics, a nonprofit biotechnology organization based in Atlanta.

Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids, that can predict toxic drug reactions. This significant development, ...